and animal populations every year. One of the ten proteins encoded by the viral genome, the 15 matrix protein M1, is abundantly produced in infected cells and plays a structural role in 16 determining the morphology of the virus. During assembly of new viral particles, M1 is 17
INTRODUCTION
structural domains to each of these interactions. Raster image correlation spectroscopy (RICS)  75 is a fluorescence-based approach that can be used to study protein binding to supported lipid 76 bilayers (SLB), thereby providing a powerful tool to investigate M1 multimerization in the 77 context of membrane binding, as we have previously demonstrated [32] . In the present study, 78
we employed RICS to analyze and compare different structural domains of M1 with regard to 79 membrane association and oligomerization: the truncated M1 constructs M1-N (aa 1-164) 80
and M1-C (aa 165-252) as well as the polybasic domain (PBD) mutant M1 m (in which all 81 basic residues in positions 95-105 were replaced by alanine residues [39] ) were compared to 82 wild-type (wt) M1. Additionally, surface plasmon resonance (SPR) measurements were 83 performed as a complementary approach to determine the affinity of these constructs to 84 negatively charged lipid membranes in the absence of any chemical modifications that might 85 perturb protein-lipid interaction. In order to investigate conformational changes that might 86 occur in M1 and each of its domains upon membrane interaction, we performed circular 87 dichroism (CD) experiments. For validation of our experimental results and further insight 88
into the details of M1-membrane interaction, we conducted molecular dynamics simulations 89 (MDS), yielding a model of M1-membrane interaction as a dynamic process at the atomic 90 level [40, 41] . Through combination of the different approaches, we provide a molecular 91
interpretation of M1-lipid interaction according to which i) M1 stably associates with a 92 negatively charged lipid bilayer via specific residues in its N-terminal domain and ii) protein-93 lipid interaction and multimerization are connected to changes in protein secondary structure 94 and intra-protein dynamics. 95
MATERIALS AND METHODS 96 97
Chemicals 98
Lipids were purchased from Avanti Polar Lipids (Alabaster, AL, USA) and used without 99 further purification: 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-100 glycero-3-phosphoserine (DOPS), 1,2-dioleoyl-triammonium-propane (DOTAP), 1,2-101 dioleoyl-sn-glycero-3-phosphoserine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (N-NBD-DOPS), 102 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (N-103 NBD-DPPE). Restriction enzymes and isopropyl-β-D-thiogalactoside (IPTG) were obtained 104 from Fermentas/Thermo Scientific (Schwerte, Germany). Phusion DNA polymerase was from 105
Finnzymes (Espoo, Finland) . Bacto tryptone, Bacto yeast extract and Bacto agar were bought 106 from BD (Heidelberg, Germany). Ampicillin, bovine serum albumin, deoxyribonuclease I 107 (DNase I), dithiothreitol (DTT), imidazole, guanidine hydrochloride, glutathione, lysozyme, 108
n-octyl-β-D-glucopyranoside and phenylmethylsulfonyl fluoride (PMSF) were bought from 109
Sigma-Aldrich (Taufkirchen, Germany). Chloramphenicol and ethylenediaminetetraacetic acid 110 (EDTA) were purchased from Serva (Heidelberg, Germany). β-mercaptoethanol and 111 spectroscopy-grade chloroform were from Merck (Darmstadt, Germany). Glucose, salts and 112 sodium/potassium phosphates were acquired from Roth (Karlsruhe, Germany), while 113
Dulbecco's phosphate buffered saline (DPBS) was acquired from PAN Biotech (Aidenbach, 114 Germany). cOmplete Ultra EDTA-free Protease Inhibitor Cocktail was purchased from Roche 115 (Basel, Switzerland) . Alexa Fluor 647 (A647) succinimidyl ester was acquired from Life 116 Technologies (Darmstadt, Germany). 117
Plasmid construction for recombinant protein production 118
The M1 open reading frame (ORF) from influenza/A/FPV/Rostock/34 was amplified from 119 plasmid pHH21-FPV-M (described in [42] ) by polymerase chain reaction (PCR) using 120 oligonucleotides M1-NdeI-fw (GGGAATTCCATATGAGTCTTCTAACCGAGGTTG-NdeI) 121
and M1-XhoI-rev (CCGCTCGAGTCACTTGAATCGTTGC-XhoI). For amplification of 122 truncated M1 sequences encoding the M1 N-terminus (M1-N, amino acids 1-164) or the M1 123 C-terminus (M1-C, amino acids 165-252), the PCR primer M1-XhoI-rev was replaced by 124 M1-N-rev (CCGCTCGAGTCACTGTCTGTGAGACCGATGC-XhoI), or M1-NdeI-fw was 125 replaced by M1-C-fw (GGGAATTCCATATGGTGGCTACCACCAATCC-NdeI), 126
respectively. The amplified sequences were subcloned into the inducible bacterial expression 127 vector pET15b (Novagen) using restriction endonucleases NdeI and XhoI, yielding plasmids 128 pET15b-M1, -M1-N and -M1-C. The final plasmid products were then controlled by 129 sequencing. For protein production, chemically competent cells of bacterial strain Rosetta 130 (DE3)pLysS were transformed with these plasmids. 131
Site-directed mutagenesis in order to replace the basic amino acids in the M1 PBD (amino 132 acids 95-105) by alanine residues was performed by two-step overlap-extension PCR. The  133  oligonucleotide  134  GCCGTCAAACTATACGCGGCGTTGGCAGCTGAGATAACATTCTATGG  and  its  135 reverse complementary oligonucleotide were used in the first step, while 136 CCAAATAACATGGATGCAGCCGTCGCACTATACGCGGCGTTGGCAGC and the 137 reverse complementary sequence were used in the second step. The M1 polybasic mutant 138 (M1 m ) ORF was then inserted into vector pET-15b and transferred into Rosetta (DE3)pLysS 139 for protein production as described above. 140 141 Protein production and purification 142 M1 protein constructs carrying an N-terminal 6x-His-tag (with a total length of 19 amino 143 acids) were expressed in Rosetta (DE3)pLysS (as described in [32] For SPR experiments, the elution buffer containing the protein was exchanged with phosphate 164 buffered saline (PBS: 16 mM Na 2 HPO 4 , 3 mM KH 2 PO 4 , 150 mM NaCl, pH 7.2) by 165 ultrafiltration using Amicon filters (Millipore Ltd., Ireland) with 10 or 3 kDa cut-off. 166 CD measurements require higher protein concentrations and, therefore, the protein 167 purification protocol was adapted to achieve higher yields by unfolding and refolding of 168 protein constructs from inclusion bodies. Details of the procedure are described in the 169
Supporting Material. 170
Fluorescence labeling 171
Purified M1 constructs were conjugated with the primary amine-reactive dye Alexa Fluor 647 172 succinimidyl ester. Freshly purified protein (in elution buffer) was incubated with 10-fold 173 molar excess of reactive dye for 18 h at 10 °C, pH 7.2. Free dye was removed by gel filtration 174
with Sephadex G-25. Protein concentration and labeling efficiency were determined by 175 absorbance at 280 nm and 650 nm, respectively. Protein concentrations were between 3 and 176 20 µM, while labeling efficiencies typically ranged between 0.1 and 0.6 dye molecules per 177 protein. 178
Preparation of supported lipid bilayers (SLBs) 180
Supported lipid bilayers (SLBs) were prepared using the "vesicle fusion method" [43] . For 181 multilamellar vesicle (MLV) formation, 70 mol% DOPC and 30 mol% DOPS were mixed in 182 chloroform and labeled with 0.5 mol% of fluorescent lipid analogue N-NBD-DOPS. The 183 solvent was evaporated, and the lipid film was rehydrated with PBS to a final concentration of 184 0.7 mg/mL lipid. The MLV suspension was diluted 5-fold and sonicated to form small 185 unilamellar vesicles, 100 µL of which were deposited on a clean glass coverslip within the 186 boundaries of a 7 mm-plastic cylinder that was attached to the glass surface. Vesicle fusion 187
and bilayer formation were induced by addition of 3 mM CaCl 2 . The volume was adjusted to 188 300 µL and the suspension was incubated for 10 min. To analyze M1 binding to the negatively charged lipid bilayers, Alexa Fluor 647-labeled M1 197 protein constructs were added to the previously prepared supported bilayer to a final 198 concentration of 50 nM (i.e.  1:100 protein/lipid ratio) and incubated for 5 min. Samples 199
were then washed five times by addition and removal of 500 µL of DPBS, immediately 200 followed by recording of RICS data. Data acquisition and analysis was performed as 201 described in Hilsch et al. [32] . Further information is also available in the Supporting 202
Material. 203
Surface plasmon resonance (SPR) 204
SPR measurements were performed on a Biacore J (Biacore AB, Uppsala, Sweden) using 205 HPP (XanTec bioanalytics GmbH) or HPA (Biacore) sensor chips. The sensor chip was 206 functionalized with a lipid monolayer according to the protocol provided by the manufacturer. 207
Briefly, the surface of the HPP chip was cleaned using N-octyl β-D-glucopyranoside (100 μl, 208 40 mM in water) for 5 min at a low flow. Lipids were mixed in chloroform at a concentration 209 of 1 mM, with the desired molar ratio (i.e. 70:30 DOPS:DOPC or 100 % DOTAP). The 210 solvent was evaporated under a nitrogen stream and lipids were resuspended by vortexing in 211 PBS (pH 7.4). The dispersion was sonicated to clarity using a bath sonicator (Emmi 20 HC, 212
Emag AG, Mörfelden-Walldorf, Germany) for 5 min. The 1 mL 1 mM liposome suspension 213 thus obtained was injected for 60 min. The chip was further washed with a 20 mM NaOH 214 solution multiple times, until producing a stable baseline with signal ranging from 2500 to 215 3200 response units (RU). This procedure resulted in the formation of a lipid monolayer on 216 the chip surface. The complete coverage of the sensor chip surface by lipids was confirmed by 217 lack of unspecific binding (i.e., <100 RU) of bovine serum albumin (10-min injection of 160 218 µL of a 1 mg/mL solution in PBS). For all experiments with M1, the control (reference) 219 sensor surface was coated with 100 % DOTAP, for which M1 has very low affinity. The drift 220 in signal for both sample and control flow cells was allowed to stabilize (<5 RU per minute) 221 before any experiments were performed. All solutions were freshly prepared, degassed and 222 filtered through 0.22-μm pores, and measurements were performed at 24 °C in PBS (pH 7.4). 223
Each protein construct was injected at concentrations ranging from 30 nM to ~3 µM (10 µM -224 130 µM for M1-C). Protein-lipid association was monitored for 20-23 min (ca. 650 µL 225 volume) to give sufficient time for the association phase to reach near-equilibrium levels. 226
Each sensorgram was then corrected by subtracting the corresponding values recorded for the 227 reference sensor. Measurements were repeated at least as four independent duplicates for each 228 M1 construct, each time using freshly purified protein samples. Binding of each protein 229 construct to DOPS/DOPC monolayers was monitored recording a corresponding sensorgram 230 (i.e. RU as a function of time). Binding curves were, in some cases, characterized by slow 231 association kinetics and complex (i.e. biphasic) behaviour. For this reason, R eq was simply 232 estimated as the maximum RU recorded after 20 min. R eq values were then plotted against 233
protein concentrations (C) and analyzed with the empirical model described in [44] : 234
where R ∞ is the value of RU at the maximum coverage of bound protein and is an 236 apparent dissociation constant of the protein from the lipid monolayer, that is, the protein 237 concentration at which half of the accessible monolayer surface is occupied. Lipid monolayer 238 regeneration was performed after each protein injection to wash away the bound protein by 239 injecting ca. 80 µL of a 10 mM NaOH solution for 1-2 min. 240
Preparation of large unilamellar vesicles (LUVs) for circular dichroism (CD) 241
measurements 242
Lipids at the desired molar ratios (100 % DOPC or DOPC/DOPS (75/25)) and 0.2 mol% N-243 NBD-DPPE were mixed in chloroform, and the solvent was evaporated under a stream of 244 nitrogen. Lipid films were redissolved in ethanol (one percent of the final volume) and finally 245 resuspended in sodium phosphate buffer (10 mM, pH 7.0) (final lipid concentration 20 mM). 246
Ten freeze-thaw cycles (in liquid nitrogen and 50°C water bath) were performed, and the 247 solution was extruded ten times through polycarbonate membrane filters with a pore size of 248 0.1 µm (Whatman GmbH, Dassel, Germany). 249
NBD fluorescence was measured (Aminco-Bowman Series 2 luminescence spectrometer, 250
Thermo Electron Corporation, Germany) to estimate equal amounts of lipid for different 251 preparations. LUVs with a concentration of 2 mM were used within two weeks, 20 mM LUV 252 suspensions were used within three days. 253
CD spectroscopy 254
Protein in sodium phosphate buffer (pH 7.0) was measured at concentrations between 5 and 255 10 µM in 1-mm cuvettes in a J-720 CD spectrometer (Jasco, Gross-Umstadt, Germany) at 256
20°C. Independent replicates were also performed in a J-815 CD spectrometer (Jasco). CD 257 spectra were recorded by accumulating five or nine spectra. In the absence of liposomes, CD 258 spectra were recorded between 185 nm and 260 nm. In the presence of liposomes, spectra 259
were acquired between 205 nm and 260 nm, since liposomes gave rise to strong light 260 scattering below 205 nm. The molar ratio between protein and lipid was ca. 1:300. 261 Normalization of the spectra was performed according to the following equation: 262
( 2) 263 where is the normalized ellipticity, CD P(+L) the measured ellipticity of the protein (plus 264 liposomes); CD B(+L) the measured ellipticity of the buffer (plus liposomes), offset the 265 calculated mean value from 258 nm to 260 nm; d the thickness of the cuvette (1 mm; 266 0.1 mm), c the protein concentration in µM, and N the number of amino acids residues in the 267 protein construct. UV spectra between 200 and 340 nm were measured prior to CD 268 acquisition to determine protein concentrations according to [45] . 269 270
Statistical tests 271
Statistical significances of differences among data sets were determined using a two-sided t-272
test with distinct variances (ttest2 routine, Matlab). In the case of asymmetric/skewed data 273 distributions, the logarithms of the corresponding data sets were compared instead. Also, we 274
verified that the use of Wilcoxon-Mann-Whitney test (rank-sum routine, Matlab) on skewed 275
data sets provided similar results. 276 277
Structural prediction and molecular dynamics simulation (MDS) of full-length M1 278
A detailed description of the methods used to perform MDS can be found in the Supporting  279 Material. 280
RESULTS 281 282
The N-terminal domain and PBD are necessary for M1-lipid interaction 283
In order to dissect the contributions of different M1 domains to the interaction with negatively 284 charged lipid membranes, four different recombinant M1 constructs were produced and 285 purified for use in in vitro membrane-binding assays: full-length wild-type (wt) M1, the 286 truncated M1 N-terminal domain (M1-N, aa 1-164), the truncated M1 C-terminal domain 287
(M1-C, aa 165-252) and a full-length M1 mutant (M1 m ) in which all six basic residues of the 288 polybasic domain (PBD, aa 95-105) were replaced by alanine residues. 289
Fluorescence-based quantification of protein binding. In a first approach to study M1-290 membrane interaction, we used fluorescence laser scanning microscopy to quantify protein 291 binding to well-defined models of the inner leaflet of the plasma membranes (i.e. supported 292 lipid bilayers, SLBs). We have previously shown that this approach can provide quantitative 293 information regarding the amount of bound M1 protein as a function of protein concentration 294 or as a function of negatively charged PS within the membrane [32] . 295
Purified M1 constructs were covalently labeled with the fluorescent dye Alexa Fluor 647 296 (A647). Labeling efficiencies were typically between 0.1 and 0.6 dye molecules per protein.
297
SLBs were produced with a composition of 70 mol% DOPC and 30 mol% DOPS as a 298
negatively charged lipid. The purified labeled protein was allowed to bind to the membrane 299
for 5 min before unbound protein was washed away. Signal intensities of bound protein were 300 measured by acquiring and averaging several confocal fluorescence images as described in 301
the Materials and Methods section. Fig. 1A shows the average frame of a representative 302 confocal image stack obtained for M1 wt bound to a SLB. Analogous images were obtained 303 for each protein construct (data not shown). Signal intensities of truncated and mutant M1 304 constructs were then normalized relative to wt M1, as shown in Fig. 1B . Both truncated M1 305 constructs, M1-N and M1-C, as well as the polybasic mutant M1 m associated to significantly 306 lower degree with the negatively charged lipid membrane, compared to M1 wt. These results 307 suggest a concurrent involvement of both N-and C-terminus in membrane binding and a 308 significant role of the PBD in M1 binding to negatively charged lipid membranes. Folding of 309 truncated and mutant M1 secondary structure was verified by circular dichroism (CD) 310 measurements as described below (Fig. 3) . 
319
Asterisks indicate statistically significant differences determined with a two-sided t-test with distinct variances: 320 (*** corresponds to p<0.01; ** corresponds to p<0.05). All measurements were conducted at room temperature. 321 322 323 324
SPR-based quantification of protein binding. Binding between lipids and the different M1-325 based constructs was further characterized using surface plasmon resonance (SPR). This 326 technique has been used in the past to quantify the interactions between lipid membranes and 327 the matrix proteins of several viruses, including HIV and Ebola [44, 46] . The main advantage 328 of this approach is that protein affinity towards model membranes can be quantitatively 329 determined without any need for labeling with, for example, a fluorescent marker. We 330 functionalized the surface of the SPR sensor chip with a monolayer composed of DOPC and 331 DOPS. In order to maximize binding and increase the S/N ratio for constructs with lower 332 membrane affinity (e.g. M1-C, see below), we increased the DOPS nominal concentration to 333 70 mol%. It is worth noting that, due to the hydrophobic nature of the interaction between 334 sensor chip and lipids, the final relative amount of DOPS in the monolayer might be lower 335 than 70 mol%. In the context of a comparison among different protein constructs, the specific 336 monolayer composition is not expected to play an important role as long as it remains 337 constant among different experiments. 338 A typical SPR measurement consisted in monitoring the binding of the protein of interest to 339 the lipid monolayer, at increasing concentrations in the range between 3 nM and ~3 µM (10 340 µM-130 µM for M1-C, due to its low affinity to membranes). Binding of the protein to the 341 monolayer was recorded in a sensorgram as an increase in response units (RU) as a function 342 of time. Fig. 2A shows an exemplary sensorgram obtained for 1 µM M1 wt. All sensorgrams 343
were corrected using a reference sample (see Materials and Methods) and the time point 0 344
corresponds to the beginning of the injection of the protein solution. The injection/binding 345 phase for each concentration C lasted ca. 20 min (see arrows in Fig. 2A ), after which a 346 dissociation phase and the regeneration of the monolayer followed (not shown). We focused 347 our attention exclusively on the estimated near-equilibrium value reached after a 20-min 348 binding phase R eq (C). Fig. 2B shows typical binding curves (i.e. R eq vs. C) for the different 349 M1 constructs.
350
Similarly to what has been previously reported (44), such curves could not be fitted by a 351 simple Langmuir adsorption isotherm, most likely because of collective adsorption, 352 electrostatic surface effects and protein-protein interaction (i.e. multimerization) during 353 membrane binding. Fitting an empirical binding model (Equation (1)) to the data, as 354 suggested in (44), we were able to analyze the binding of M1, M1-C, M1-N and M1 m to 355 DOPC/DOPS monolayers, thus obtaining a maximum protein load ( ∞ ) and an apparent 356 dissociation constant ( ). represented for example in Fig. 2B were analyzed using equation (1) . R ∞ is the amount of RU at the maximum 389 coverage of bound protein, and is an apparent dissociation constant of the protein to the lipid monolayer, 
Conformation of full-length M1 and its C-terminal domain is modulated by membrane 396
binding 397 398
To compare the structural rearrangement of M1 constructs upon membrane interaction, CD 399 measurements were performed in the presence and absence of liposomes. In this experimental 400 setup, large unilamellar vesicles (LUVs) of different lipid compositions were used to study 401 M1 membrane binding. DOPS-containing LUVs were compared to neutral liposomes 402 prepared from pure DOPC. For all four protein constructs (i.e. M1, M1 m , M1-N and M1-C), 403 CD spectra obtained in the presence of DOPC-liposomes did not differ from CD spectra 404 obtained in buffer (Fig. 3) , indicating that there either are no interactions with neutral 405 liposomes or that any such interactions are not accompanied by changes in secondary 406 structure composition. These results are consistent with previously reported CD spectra of M1 407 constructs in solution [33, 37, 47] and with former findings indicating only very weak 408 association of M1 with neutral PC membranes [21, 32] . The estimated secondary structure 409 contents were found to be comparable to those previously reported [33] (data not shown). In 410 the presence of negatively charged liposomes containing DOPS, however, the spectra of three 411 of the constructs (i.e. M1, M1 m and M1-C) displayed moderate, yet significant alterations 412 compared to measurements performed in the absence of lipid vesicles. Such alterations might 413 be brought about either by small structural rearrangements in a large number of molecules 414 that associate with the liposomes or by limited binding of a subpopulation of protein 415 molecules that is accompanied by more pronounced structural rearrangements. The CD data, 416 therefore, do not provide direct information about the membrane affinities of the different 417 constructs (i.e. the fractions of bound protein). For the N-terminal domain alone (M1-N), no 418 conformational change could be observed in the presence of DOPS-containing lipid bilayers. 419
This does not necessarily exclude binding of M1-N to these membranes, but rather suggests 420 that-if there is binding, as observed in SPR measurements (Fig. 2) 
428
Purified proteins (5-7 µM) were mixed with LUVs (1.6 mM) and incubated for 1 h at room temperature in PBS.
429
Nine spectra were acquired and averaged for each sample and for at least two independently purified protein 430 batches. All measurements were conducted at room temperature. Fluorescence laser scanning microscopy can also be used to measure protein-protein 442 interaction for the different fluorescent M1 constructs bound to SLBs. We performed RICS 443 analysis, a quantitative fluorescence microscopy approach that provides diffusion coefficients 444 and the relative molecular brightness of membrane-bound proteins assemblies [32] . The latter 445 is a measure of the multimerization state of the protein. To this end, stacks of 100 images 446
were acquired, and independently moving fluorescent entities were detected by analysing the 447 fluorescence fluctuations among pixels. Note that these independently diffusing objects can 448 be monomers or multimeric complexes, which yield different brightness values. The 449
brightness is defined as the total fluorescence intensity of membrane-bound protein divided 450 by the number of protein clusters detected, thus indicating the degree of clustering in the 451 sample (or the relative amount of M1 molecules per cluster). On the one hand, higher-order 452 multimers are characterized by higher brightness values. On the other hand, the diffusion 453 coefficient provides information regarding both size of protein assemblies (i.e. large protein 454 multimers diffuse slowly) and protein-membrane interaction (i.e. proteins loosely bound to 455 the membrane surface will diffuse faster [48]). 456
As shown in Fig. 4A , M1 wt bound to SLBs containing 30 mol% DOPS has a diffusion 457 coefficient of (0.29 ± 0.03) µm 2 /s, in agreement with previous estimates (32), while the 458 diffusion coefficient of M1-C was found to be significantly larger at (0.91 ± 0.07) µm 2 /s, 459
clearly indicating slower dynamics of wt M1, as compared to M1-C. Consistently, the 460 brightness of wt M1 was ~4.3-fold higher than that of M1-C, suggesting that M1-C has a 461 lower tendency to oligomerize as compared to full-length M1 (Fig. 4B ). Diffusion coefficients 462 of M1 m and M1-N were found to be closer to wt values (only ~2-fold higher in average). 463
Also, the brightness of M1 m was not significantly different from the brightness of full-length 464 M1 wt, suggesting oligomerization of both constructs to be similar. 465 466 467 Structure and intramolecular dynamics of full-length M1 monomer obtained via MDS 479
As a complementation to our experimental investigations, we performed MDS in order to gain 480 information on the details of M1-lipid interaction at the atomic level. We first started with the 481 analysis of a single M1 monomer in solution. One possible model for the structure of the full-482 length protein ( Fig. 5A and B) was obtained by combining the known structure of M1 N-483
terminal domain (PDB ID 1EA3), composed of α-helices H1 to H10, with separate ab initio 484
modelling of the C-terminal domain. Furthermore, we calculated the minimum free-energy 485
orientation of the C-terminal domain with respect to the N-terminal domain, as described in 486
the Materials and Methods section. The structure obtained for M1-C consists of three α-487 helices (namely, H11, H12 and H13), in agreement with a previous prediction based on the 488 M1-C amino acid sequence and bioinformatics tools [37] . In our model, the three M1-C α-489 helices align approximatively parallel to the M1-N surface provided by α-helices H1, H2, H7 490 and H9, in line with previous reports [49] . 491 In order to test the stability and dynamics of the M1 structure, a 500-ns MDS of the full-492 length protein was performed. The protein reached a stable conformation after ca. 400 ns, as 493
shown by the root-mean-squared displacement (RMSD) values depicted in Fig. 5C . 494
Moreover, normal-mode analysis [50] of residue dynamics revealed a "hot", highly flexible 495 region among the helices in the M1-C domain characterized by a large amplitude of the first 496 "breathing" mode (highlighted red in Fig. 5D ), while the other regions of the protein remained 497 comparatively rigid (highlighted in blue). The observed flexibility of the C-terminal domain is 498 in agreement with a previous theoretical analysis [37] and small-angle X-ray scattering 499
investigations [36] . Another small, but flexible loop can be further observed between helices 500 H5 and H6 of the N-terminal domain (aa 8286, Fig. 5D ). 501 502 503 
512

Binding of an M1 monomer to a model membrane studied by MDS 514
To obtain more precise information regarding the binding of a single M1 monomer to a lipid 515 membrane, various spatial configurations of the M1-membrane system were evaluated, as 516 described in the Materials and Methods section and Fig. S2 . Briefly, the protein was slowly 517 translated towards the membrane surface using eight different orientations relative to the 518 membrane plane. Upon reaching the membrane, only one orientation resulted in a non-519 diverging MDS and a stable interaction between the protein and the DOPC/DOPS model 520 membrane. The other seven orientations tested led to configurations in which the protein did 521 not remain bound to the membrane (in the absence of a pulling force), as shown in Fig. S3 . 522
The protein-membrane system exhibiting the most stable interaction (the second in Fig. S2 ) 523
was further simulated for a total of 500 ns. The final result shown in Fig. 6A and B indicates 524 that the M1 N-terminal domain mediates the interaction with the membrane, while C-terminal 525 domain does not directly interact with lipids (i.e., it is on the distal side of the protein). More 526 specifically, in our model, the membrane-interacting region was found to include helix H5 (aa 527 78 to 84) and two surrounding loops (aa 68 to 78 and 84 to 88) that approximately correspond 528 to the region denoted in red in Fig. 6A and B . Arginine and glutamine residues from this 529 region establish direct interactions with components of the membrane. In detail, arginine 530 residues interact with PS head groups, while two glutamine residues (Gln75 and Gln81) 531 display interactions with PC head groups. Some of these interactions can be seen in closer 532 detail in Fig. 6C . As shown in Fig. 6D , the distances between the glutamine residues and the 533 closest PC head groups (N-P atom distances) consistently reach values as low as 4 Å, 534
indicative Interestingly, the PBD of M1 on helix 6 (displayed in green in Fig. 5A , with basic residues in 548 stick representation) is not stably involved in direct interactions between the protein and the 549 membrane in our model. More intriguingly, another region on helix 5 including the arginine 550 triplet in position 76-77-78 appears to be interacting specifically with the negatively charged 551 head group of DOPS during the whole simulation (Fig. 6C) . The positively charged side 552 chains of Arg76 and Arg78 are consistently involved in a short-distance interaction with the 553 head groups of DOPS molecules. Distances between arginine residues 76, 77 and 78 and the 554 three closest PS head groups are shown in Fig. 7AC . Arg76 and Arg78-but not Arg77-are 555 found in close proximity to a PS head group during several periods of the simulation (e.g., 556
green curves in panels A and C, often and consistently below 3-4 Å), suggesting strong 557
protein-lipid interactions [52] . In order to better quantify these interactions, we calculated 558 radial distribution functions, as previously described [53] . The curves shown in Fig. 7D  559 indicate a high probability to find a P atom of a DOPS molecule at short distances from Arg 560 76 and 78 (e.g., probability peak at 2.7 Å distance). The same analysis for Arg77 does not 561 suggest a specific interaction with DOPS molecules. Similar interactions among adjacent 562 arginine residues and acidic epitopes have been also previously described [54] . 563 
570
Binding to lipid membranes restricts M1 intramolecular dynamics 571
A comparison of residue dynamics of M1 in solution and in the membrane-bound state can be 572
performed by comparing the root-mean-squared fluctuations (RMSF) calculated from 573 equilibrium simulations for both systems, as presented in Fig. 8 . In agreement with the results 574 obtained from normal mode analysis (Fig. 5D) , the most flexible region of M1 in solution was 575
found in the C-terminal domain of the protein, featuring an RMSF peak greater than 3 Å. 576
Interestingly, an overall reduction of the fluctuation was observed for the full-length protein 577 upon interaction with the lipid membrane (blue curve in Fig. 8 ). Notwithstanding the fact that 578 the association of M1 with the membrane occurs through the N-terminal domain, binding of 579 the protein to lipids seems to induce a significant stabilization also of the C-terminal domain, 580
as noted by the reduction in the flexibility observed for this region. Notably, the peak 581 corresponding to residues 8286 of the N-terminus, which in the protein structure represents 582 the loop neighbouring the membrane-bound triplet of arginine residues and membrane-583
interacting glutamine residues (Fig. 6) , is significantly reduced upon membrane association of 584 the protein. 600  601  602  603  604  605  606  607  608 
